Cargando…

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma

Increased glycolysis has been reported as a major metabolic hallmark in many cancers, and is closely related to malignant behavior of tumors. However, the potential mechanism of glycolysis in hepatocellular carcinoma (HCC) and its prognostic value are not well understood. To address this, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Tuo, Ye, Qian, Jin, Chen, Wu, Mingliang, Chen, Kaiyu, Yang, Jinhuan, Chen, Ziyan, Yu, XiXiang, Chen, Gang, Wang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993684/ https://www.ncbi.nlm.nih.gov/pubmed/33686959 http://dx.doi.org/10.18632/aging.202613

Ejemplares similares

Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
por: Jin, Chen, et al.
Publicado: (2021)

Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma
por: Yang, Jinhuan, et al.
Publicado: (2022)

Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
por: Chen, Dan, et al.
Publicado: (2023)

Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis
por: Deng, Weijie, et al.
Publicado: (2022)

A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma
por: Chen, Jida, et al.
Publicado: (2022)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

The prognostic value of sarcopenia combined with preoperative fibrinogen–albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study
por: Yu, Haitao, et al.
Publicado: (2021)

Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape
por: Gui, Chengpeng, et al.
Publicado: (2023)

Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis
por: Liu, Dazhong, et al.
Publicado: (2021)

Endovascular Repair of Persistent Sciatic Artery With Limb Ischemia: A Wrong Choice?
por: Deng, Liming, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma
por: Jiang, Longyang, et al.
Publicado: (2019)

A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA
por: Li, Hanwen, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for neuroendocrine prostate cancer, based on the SEER database
por: Chen, Siming, et al.
Publicado: (2023)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021)

Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer
por: Liu, Gang, et al.
Publicado: (2022)

FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma
por: Lei, Shixiong, et al.
Publicado: (2016)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Privacy preserving validation for multiomic prediction models
por: Ahmed, Talal, et al.
Publicado: (2022)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma
por: Wu, Zhicheng, et al.
Publicado: (2022)

A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinoma
por: Chen, Zhihong, et al.
Publicado: (2021)

Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
por: Zhang, Qi, et al.
Publicado: (2019)

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets
por: Li, Ji, et al.
Publicado: (2021)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic Glycolysis
por: Chen, Ya, et al.
Publicado: (2022)

A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma
por: Feng, Yilu, et al.
Publicado: (2020)

Multiomics Study Reveals Enterococcus and Subdoligranulum Are Beneficial to Necrotizing Enterocolitis
por: Lin, Hao, et al.
Publicado: (2021)

Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model
por: Zhang, Enchong, et al.
Publicado: (2021)

Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma
por: Yang, Yang, et al.
Publicado: (2021)

Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer
por: Wu, Zhengyuan, et al.
Publicado: (2021)

Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches
por: Xiao, Zixuan, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
por: Liu, Ziyu, et al.
Publicado: (2020)

A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
por: Jin, Xinmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tmo9pokr0712n4egdkhpb7ta3